Matches in Wikidata for { <http://www.wikidata.org/entity/Q94677789> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q94677789 description "article scientifique publié en 2020" @default.
- Q94677789 description "artykuł naukowy opublikowany 14 maja 2020" @default.
- Q94677789 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q94677789 description "im Mai 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q94677789 description "scientific article published on 14 May 2020" @default.
- Q94677789 description "wetenschappelijk artikel" @default.
- Q94677789 description "наукова стаття, опублікована 14 травня 2020" @default.
- Q94677789 name "Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri® Observational Program (TOP)" @default.
- Q94677789 name "Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri® Observational Program (TOP)" @default.
- Q94677789 type Item @default.
- Q94677789 label "Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri® Observational Program (TOP)" @default.
- Q94677789 label "Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri® Observational Program (TOP)" @default.
- Q94677789 prefLabel "Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri® Observational Program (TOP)" @default.
- Q94677789 prefLabel "Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri® Observational Program (TOP)" @default.
- Q94677789 P1433 Q94677789-E84189A3-E432-4D10-B770-9E585A7F95AA @default.
- Q94677789 P1476 Q94677789-0C9593A8-6FD1-488B-8EE0-DC71B370F2BF @default.
- Q94677789 P2093 Q94677789-006C090A-A22E-4373-A7A7-C731645365D1 @default.
- Q94677789 P2093 Q94677789-03A640A5-67E9-46C1-BC4F-15B7C23FC16F @default.
- Q94677789 P2093 Q94677789-1566BD52-69CE-4A49-887C-AD1B095EC46B @default.
- Q94677789 P2093 Q94677789-1CFC3457-BD45-48F5-AC57-13D0255DE984 @default.
- Q94677789 P2093 Q94677789-60FF1761-1E54-4E7D-AE12-E924AB046D3B @default.
- Q94677789 P2093 Q94677789-7C60116D-F2A4-4940-91E5-F3FFB30EBA09 @default.
- Q94677789 P2093 Q94677789-A061CE49-281D-4C49-9D48-1E019DF8DFA6 @default.
- Q94677789 P304 Q94677789-686EA82E-26DC-4F82-A916-C94614CF2502 @default.
- Q94677789 P31 Q94677789-D68B0F72-F0C5-4B3D-968A-23775D2375D9 @default.
- Q94677789 P356 Q94677789-9569DEED-9BC1-4EC0-84FD-7ACDF5AE5E47 @default.
- Q94677789 P50 Q94677789-47AB4422-45E2-4A48-A482-94E9DB4841AF @default.
- Q94677789 P50 Q94677789-87F0C7AD-C702-45A7-8C77-50EA9D9414B9 @default.
- Q94677789 P50 Q94677789-B1CEDD9A-323A-4D63-A9F3-80F8EA8A095F @default.
- Q94677789 P577 Q94677789-947E79A4-4A1C-4452-AF43-0D2C4225270C @default.
- Q94677789 P698 Q94677789-5E8A2BC0-CD40-4C7B-B61C-220DA6C0B7F3 @default.
- Q94677789 P356 1352458520917925 @default.
- Q94677789 P698 32406786 @default.
- Q94677789 P1433 Q1952449 @default.
- Q94677789 P1476 "Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri® Observational Program (TOP)" @default.
- Q94677789 P2093 "Helmut Butzkueven" @default.
- Q94677789 P2093 "Karen Rosales" @default.
- Q94677789 P2093 "Maria Trojano" @default.
- Q94677789 P2093 "Nolan Campbell" @default.
- Q94677789 P2093 "Pei-Ran Ho" @default.
- Q94677789 P2093 "Ray Su" @default.
- Q94677789 P2093 "Stephanie Licata" @default.
- Q94677789 P304 "1352458520917925" @default.
- Q94677789 P31 Q13442814 @default.
- Q94677789 P356 "10.1177/1352458520917925" @default.
- Q94677789 P50 Q27583547 @default.
- Q94677789 P50 Q57912848 @default.
- Q94677789 P50 Q90186549 @default.
- Q94677789 P577 "2020-05-14T00:00:00Z" @default.
- Q94677789 P698 "32406786" @default.